COVID-19 and the Drug Shortage From India

Shoab Malek is a pharmaceutical consultant and a GMP auditor, located in India. He talked to Yan Kugel about the big challenges that India faces because of COVID-19. Being the biggest generic pharmaceutical exporter in the world, it may influence the whole world. The prices in India for many drugs have already doubled or tripled, for many reasons:

• Raw material shortage
• Packaging material shortage
• Shortage of skilled workers
• Not enough storage places for finished goods
• The supply chain to the rest of the world has completely stopped

The videocast is available on

www.qualistery.com